Reckitt and Benckiser both began life in the 19th century eventually merging over 100 years later in 1999 to become the worlds largest household cleaning products group. Over half the groups revenues are generated from its Fabric Care and Surface Care divisions, with the majority of its business centred in Western Europe. In 2005 Reckitt added the Nurofen, Strepsil and Clearasil brands to its portfolio with the £1.9bn acquisition of Boots Healthcare International.


Updates from The Motley Fool

Latest updates on Reckitt Benckiser from Fool.com.


Stock Performance

RB vs. S&P 500 | 2 Year Performance
View Interactive RB Charts
Sponsored by

Key Data Points

Primary metrics and data points about Reckitt Benckiser .
Current Price: $7,193.62
Prev Close: $7,438.00
Open: $7,300.00
Bid: $7,020.00
Ask: $7,550.00
Day's Range: $7,070.00 - $7,364.00
52wk Range: $5,403.00 - $7,786.00
Volume: 2,498,361
Avg Vol 1,381,031
Market Cap: $5,065.39B
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Reckitt Benckiser .
CAPS Rating 0 out of 5
 
0 Outperform
0 Underperform
CAPS All Stars
 
0 Outperform
0 Underperform

How do you think Reckitt Benckiser will perform against the market?



You pick for Reckitt Benckiser is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Rakesh Kapoor, CEO

73% Approve

Based on 230 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Reckitt Benckiser .

Reckitt and Benckiser both began life in the 19th century eventually merging over 100 years later in 1999 to become the worlds largest household cleaning products group. Over half the groups revenues are generated from its Fabric Care and Surface Care divisions, with the majority of its business centred in Western Europe. In 2005 Reckitt added the Nurofen, Strepsil and Clearasil brands to its portfolio with the £1.9bn acquisition of Boots Healthcare International.

  • Exchange: LSE